Rare diseases
Investigational molecules
Locations
Back to Germany987 clinical trials in Heilbronn, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of Secukinumab for Patients with New-Onset Giant Cell Arteritis in Clinical Remission
GermanyStudy on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis
GermanyStudy Comparing Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin versus High-Dose Chemotherapy with Paclitaxel and Drug Combination for Relapsed Germ Cell Tumors
GermanyStudy of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality
GermanyStudy on Abemaciclib and Endocrine Therapy for Patients with Advanced Hormone Receptor Positive HER2 Negative Breast Cancer
GermanyStudy of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors
GermanyComparison of allogeneic stem cell transplantation versus conventional therapy in patients with multiple myeloma who relapsed after first-line therapy
GermanyStudy on the Effectiveness and Safety of Cisplatin, Carboplatin, Etoposide, and Durvalumab in Patients with Limited Stage Small Cell Lung Cancer
GermanyStudy of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors
GermanyStudy of Elranatamab for Patients with Multiple Myeloma Resistant to Proteasome Inhibitors, Immunomodulatory Drugs, and Anti-CD38 Antibodies
GermanyStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
GermanyStudy Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia, testing novel drug combinations to improve patient outcomes. Research includes evaluating treatments for both adult and pediatric patients with various forms of leukemia.
Studies aim to enhance survival rates and develop more effective treatment strategies for blood cancer patients.
Comprehensive studies addressing different types of breast cancer, particularly focusing on triple-negative breast cancer and HER2-positive disease. Research includes both early-stage and metastatic disease treatments.
Trials evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Research focusing on various digestive system cancers, including gastric cancer, colorectal cancer, and pancreatic cancer. Studies evaluate both early-stage and advanced disease treatments.
Investigations aim to improve surgical outcomes and treatment effectiveness for GI cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
